Clinical trial · Interventional
Providing Cancer Care Closer to Home for Patients With Multiple Myeloma
A Natural Experiment of Providing Cancer Care Closer to Home for Patients With Multiple Myeloma
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Insufficient funding
Summary
Brief summary (as posted)
There is very limited data on the utilization of National Cancer Institute Comprehensive Cancer Center (NCI-CCC) satellite sites in general. Of what is available, most is in regards to providing chemotherapy at facilities closer to patients' home. These "satellite chemotherapy infusion centers", typically community-based treatment locations at community hospitals/facilities, freestanding clinics, or mobile units, are reported to be well liked by patients who utilize their services and reduce their travel times and expenses. In these studies patients still remained in the care of their current provider and site and are required to travel to the site for clinical visits and other appointments. It is currently unknown if patients are willing to transfer their care to a different provider to alleviate travel burden. In addition, although increased travel burden has been lower quality of life in cross-sectional studies, no data exists suggesting that these reducing travel burden can improve these outcomes intra-patient, to the knowledge of the investigators. The patient roles of the multiple myeloma clinical providers at the Siteman primary location have grown in recent years. The providers have determined a need to refer some patients to the satellite sites to relieve congestion at the site while also hopefully improving the clinical experience for those patients. This study is a natural experiment of this process.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Multiple Myeloma | Multiple Myeloma | CURATED_EXACT | 0.92 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Care transition | Other | — | UNRESOLVED |
| No care transition | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Care transition
- description
- -At baseline, the participant and the provider will make a decision on if the participant will transfer care to a satellite location.
- interventionNames
- Other: Care transition
- type
- ACTIVE_COMPARATOR
- label
- No care transition
- description
- -At baseline, the participant and the provider will make a decision on if the participant will transfer care to a satellite location.
- interventionNames
- Other: No care transition
Primary outcomes (1)
- measure
- Proportion of eligible participants who successfully transfer to the provider at a satellite location
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Eligibility Criteria * At least 18 years old * Diagnosed with multiple myeloma * Receiving care from a provider within the Division of Oncology at the primary Siteman Cancer Center site * Resides within the catchment area of a Siteman Cancer Center satellite site * Able to read, speak, and understand English * Willing to provide informed consent
References
Publications (0)
Data not yet available